High Point Advisor Group LLC Benitec Biopharma Inc. Transaction History

High Point Advisor Group LLC

  • $1.76 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021
SELL
$3.94 - $5.81 $366,420 - $540,330
-93,000 Closed
0 $0
Q1 2021

Apr 12, 2021
BUY
$2.59 - $9.26 $240,870 - $861,180
93,000 New
93,000 $462,000

Others Institutions Holding BNTC

# of Institutions
3
Shares Held
1.42M
Call Options Held
0
Put Options Held
0
View Full List

About Benitec Biopharma Inc.

BNTC Quotes by TradingView
  • Ticker BNTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,809,500
  • Market Cap $280M
  • Description
  • Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...
More about BNTC
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email